Discover how machine learning predicts sepsis-associated ARDS and mortality with high accuracy. Learn about the potential for ...

A NEW study has demonstrated the diagnostic superiority of [68Ga]Ga-NYM046 PET/CT over the conventional [18F]FDG PET/CT in ...

A new scoring system identifies risk factors for disease recurrence after stem cell transplantation in leukemia patients, ...

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales. Read more.

Discover a study that shows that modulating STAT6 directly may represent an innovative strategy for managing severe, ...

Phase 3 psoriasis trial results highlight the efficacy and safety of icotrokinra, an oral IL-23 therapy showing promise for ...

New research reveals rare aneuploid cells in healthy breast tissues, showing cancer-like mutations that increase with age, ...

Pfizer's anti-tissue factor pathway inhibitor has been approved for the treatment of haemophilia A & B by the European Commission.

Phase 1 trial demonstrates safety and effectiveness of neoantigen DNA vaccines in triple-negative breast cancer, achieving 87.5% recurrence-free survival at 36 months.

Discover how kidney function decline in ATTR-CM patients predicts higher mortality, highlighting its role as a critical marker in disease management and care optimisation.

Discover how combining brain stimulation therapies improves depression treatment outcomes compared to single therapies, ...

This new research sheds light on shared and subtype-specific genetic variations and points to potential targets ...